Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Interview with Dallas Webb, portfolio manager BB Biotech about what the future holds for biotechnology, how Covid-19 has played a role in accelerating adoption of emerging therapies, and what some of the most exciting developments are in the sector. Read the whole interview on Investment Week.

BB Biotech's Dallas Webb: «The fundamentals of biotech have never been stronger»

Interview with Dallas Webb, portfolio manager BB Biotech about what the future holds for biotechnology, how Covid-19 has played a role in accelerating adoption of emerging therapies, and what some of the most exciting developments are in the sector. Read the whole interview on Investment Week.
25.01.2022 - Dallas Webb

These investment strategies might interest you

  • BB Biotech AG

    BB Biotech AG (SIX) (CHF)
    ISIN-No.: CH0038389992YTD: 26.76%Active share: 79.47Anzahl Positionen: 22
    Launch date: 16. November 1993